Penn State University

1. Incyte Corporation $307,613 10 payments
2. Alcon Research LLC $140,786 3 payments
3. Endotronix, Inc. $107,641 4 payments
4. Pfizer Inc. $71,291 23 payments
5. Boehringer Ingelheim Pharmaceuticals, Inc. $65,000 1 payment
6. Bard Peripheral Vascular, Inc. $35,619 2 payments
7. AveXis $23,768 17 payments
8. Ocular Therapeutix, Inc. $17,283 1 payment
9. Jazz Pharmaceuticals Inc. $17,000 3 payments
10. Genentech, Inc. $5,750 5 payments

1. Exploratory Trial of Topical Ruxolitinib for Early Stage Hidradenitis Suppurativa $145,655 5 payments
2. A Single-Center, Double-Arm, Prospective Clinical Trial to Compare Visual Performance and Patient Reported Outcomes of Non-Diffractive Extended Depth of Focus and Neutral Aspheric Monofocal Intraocular Lenses $125,148 2 payments
3. Exploratory Trial of Topical Ruxolitinib for Early Stage Hidradenitis Suppurativa $88,600 3 payments
4. Study name not reported $72,757 1 payment
5. US SAG 2021 00003323 Trustees of the University $65,000 1 payment
6. Proactive-Hf $63,514 2 payments
7. A Randomized Phase II Trial of Salvage Radiotherapy With Standard VS Enhanced Androgen Deprivation Therapy With Enzalutamide in Patients With Postprostatectomy Psa Recurrences With Aggressive Disease Features $48,200 15 payments
8. Proactive-Hf $44,127 2 payments
9. Lutonix Av Pas Cl003301 $35,619 2 payments
10. A Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy $23,768 17 payments

1. Patient care $55,602 3 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.